Metraipolis › archive › dc_7ae4d740243f
Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma — Europe PMC PMID:41697437
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41697437
- DOI
- 10.1007/s13402-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T18:14:02.004Z
- SHA-256 of the archived text
1054ec9269c7bd4272ed1e5e698a983ec527ad1f20d19c1707a8bdba22206d73- Stable URL of this page
https://metraipolis.com/documento/dc_7ae4d740243f
How to cite
Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma — Europe PMC PMID:41697437 — Europe PMC (en), https://europepmc.org/article/MED/41697437 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ae4d740243f (Metraipolis archive dc_7ae4d740243f, sha256 1054ec9269c7bd4272ed1e5e698a983ec527ad1f20d19c1707a8bdba22206d73)
BibTeX
@misc{dc7ae4d740243f,
title = {Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma — Europe PMC PMID:41697437},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41697437},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ae4d740243f; sha256 1054ec9269c7bd4272ed1e5e698a983ec527ad1f20d19c1707a8bdba22206d73},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41697437. Agents can read the archived copy with the MCP tool read_document.